iodoaminopotentidine has been researched along with colforsin in 1 studies
Studies (iodoaminopotentidine) | Trials (iodoaminopotentidine) | Recent Studies (post-2010) (iodoaminopotentidine) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
---|---|---|---|---|---|
18 | 0 | 0 | 13,460 | 46 | 1,298 |
Protein | Taxonomy | iodoaminopotentidine (IC50) | colforsin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alewijnse, AE; Leurs, R; Roovers, E; Smit, MJ; Timmerman, H; van de Vrede, Y | 1 |
1 other study(ies) available for iodoaminopotentidine and colforsin
Article | Year |
---|---|
Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists.
Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Sequence; Animals; Base Sequence; CHO Cells; Cholera Toxin; Colforsin; Cricetinae; Cyclic AMP; DNA Primers; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression; Guanidines; Histamine; Histamine Agonists; Histamine H2 Antagonists; Iodine Radioisotopes; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Radioligand Assay; Rats; Receptors, Histamine H2; Recombinant Proteins; RNA, Messenger; Transfection | 1996 |